{"id":724911,"date":"2023-01-23T07:33:10","date_gmt":"2023-01-23T12:33:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/"},"modified":"2023-01-23T07:33:10","modified_gmt":"2023-01-23T12:33:10","slug":"intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/","title":{"rendered":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development"},"content":{"rendered":"<h2>\nAchieves Record 4x Improvement in Time-To-Result to Provide\u00a0Test Results in Under 1 Minute<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Jan.  23, 2023  (GLOBE NEWSWIRE) &#8212; Intelligent Bio Solutions Inc. (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a phase of its biosensor platform development at the University of Newcastle, Australia, that included testing time-to-result (TTR), sensitivity, and reproducibility. The results showed a record 4x improvement in TTR, enabling the biosensor to return test results in under one minute.<\/p>\n<p align=\"justify\">The Company\u2019s biosensor platform is the world\u2019s first platform designed to specifically support multiple non-invasive, real-time, saliva-based diagnostic tests based on Organic Thin Film Transistor (OTFT) technology. It features a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.<\/p>\n<p align=\"justify\">\n        <em>\u201cWe are thrilled to have reached another key development milestone for our biosensor platform, particularly demonstrating a substantial TTR reduction from 120 to 30 seconds, far below our original target of over 1 minute per test,\u201d <\/em>said Harry Simeonidis, Chief Executive Officer at Intelligent Bio Solutions.<em> \u201cBased on these successful results, the biosensor development team has now proceeded to its next testing phase, which will include testing human saliva.\u201d<\/em><\/p>\n<p align=\"justify\">Further improvements to the biosensor platform observed in the results of Milestone 7 include:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;text-align:justify\">The development and application of a <strong>new ink and device architecture<\/strong> that shows significant improvements in performance. These changes have not only reduced TTR<sup>i<\/sup> by a factor of four, but have also significantly reduced manufacturing and printing times &#8211; improving productivity, and reducing costs.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Improvements in the limit of detection<\/strong> which is critical when measuring glucose in saliva. Before these recent improvements, the biosensor platform was achieving 0.90 mg\/dl<sup>ii<\/sup>. Setting a more aggressive target initially improved this to 0.54 mg\/dl, before later achieving a further reduction to 0.36 mg\/dl on average with the lowest result being 0.22 mg\/dl.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <em>\u201cThese Milestone 7 results highlight important improvements achieved during the ongoing development of the biosensor platform technology. We expect these enhancements will help accelerate our planned work on future biomarker targets for hormones, allergens, and cancers,\u201d <\/em>added Professor Paul Dastoor, Director, Center for Organic Electronics at the University of Newcastle, Australia.<\/p>\n<p align=\"justify\">\n        <strong>About Intelligent Bio Solutions Inc. <\/strong>\n      <\/p>\n<p align=\"justify\">Intelligent Bio Solutions Inc. is a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions to customers globally. With its world-first biosensor platform, Intelligent Bio Solutions is developing and launching diagnostic tests urgently needed to help people living with chronic disease. In addition, through its recent acquisition of Intelligent Fingerprinting, the company is the world leader in the advancement of portable drugs of abuse testing through the analysis of fingerprint sweat. The system is a platform technology with potential applications in many areas of diagnostics, and its advantages include being non-invasive, hygienic, fast, and cost-effective. The top-selling product screens for recent use of the most commonly taken drugs in workplace settings; opioids, cocaine, methamphetamine, and marijuana. Sample collection takes just seconds, with results in ten minutes. Customers include employers in safety-critical industries such as construction, transport and logistics firms, drug treatment organizations, as well as UK coroners. A laboratory confirmation service is also available.<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FSSPmIHqGrZQ_aHZGVhZHEN8CvdvAzEFFufUXm4suchKYBS2Eg8gH0LsFRv2L3wmadJ6DRH9VCMz2ohcLf933A==\" rel=\"nofollow noopener\" target=\"_blank\">www.ibs.inc<\/a><\/p>\n<p>        <strong>Forward-Looking Statements:<\/strong>\n      <\/p>\n<p align=\"justify\">Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.\u2019s ability to develop and commercialize its diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although\u00a0Intelligent Bio Solutions Inc.\u00a0believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements.\u00a0Intelligent Bio Solutions Inc.\u00a0has attempted to identify forward-looking statements by terminology, including &#8221;believes,&#8221; &#8221;estimates,&#8221; &#8221;anticipates,&#8221; &#8221;expects,&#8221; &#8221;plans,&#8221; &#8221;projects,&#8221; &#8221;intends,&#8221; &#8221;potential,&#8221; &#8221;may,&#8221; &#8221;could,&#8221; &#8221;might,&#8221; &#8221;will,&#8221; &#8221;should,&#8221; &#8221;approximately&#8221; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions\u2019 public filings filed with the\u00a0Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.<\/p>\n<p align=\"justify\">\n        <strong>Company Contact: <\/strong><br \/>\n        <br \/>Intelligent Bio Solutions Inc. <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JybsgOrgAEc-RFNZwMU4xieCreNDI7Uz34CiLUuUbHrlbG2VLG0qUH9g_m5R5KUqSyOyv9SSiJp6YSntw1-bTA==\" rel=\"nofollow noopener\" target=\"_blank\">info@ibs.inc<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact: <\/strong><br \/>\n        <br \/>Cheryl Billson <br \/>Comma Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M7MTLqhNXcQMJa2i8tHlo_O-xQLVcJJ4VuzzDyPWP03TlBMVOXXqZx4RECkC7WkAa7HgllxjX52E755yNTxfmfmOYz-2UYY6LZEGLLZEdoc9X-DimDXboeK9NY1VzFN-\" rel=\"nofollow noopener\" target=\"_blank\">cheryl.billson@commacomms.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Valter Pinto<br \/>KCSA Strategic Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zbhzl8zb2eluJ2UUySn9wdlZRV4SwJU7aaJjgMTVYkd3p0_Fx0tvD0Q_M8H2M24s3roUbWXaR0XHHVwIfyIAGw==\" rel=\"nofollow noopener\" target=\"_blank\">INBS@kcsa.com<\/a><\/p>\n<p>\n        <sup>__________________________<br \/>i<\/sup> TTR is the measurement time for the test, which is taken from the start of testing until a result has been produced<br \/><sup>ii<\/sup> The unit for reporting glucose concentration in the USA is mg\/dL, or milligrams per 100 milliliters. The international standard unit for reporting the concentration of glucose in blood is mmol\/l.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWNhZjBiOWYtZjg4YS00MmE3LTg4ZmMtMzY2MDM2NzY4MDQ0LTEyMDExMTg=\/tiny\/Intelligent-Bio-Solutions-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Achieves Record 4x Improvement in Time-To-Result to Provide\u00a0Test Results in Under 1 Minute NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Intelligent Bio Solutions Inc. (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a phase of its biosensor platform development at the University of Newcastle, Australia, that included testing time-to-result (TTR), sensitivity, and reproducibility. The results showed a record 4x improvement in TTR, enabling the biosensor to return test results in under one minute. The Company\u2019s biosensor platform is the world\u2019s first platform designed to specifically support multiple non-invasive, real-time, saliva-based diagnostic tests based on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-724911","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Achieves Record 4x Improvement in Time-To-Result to Provide\u00a0Test Results in Under 1 Minute NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Intelligent Bio Solutions Inc. (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a phase of its biosensor platform development at the University of Newcastle, Australia, that included testing time-to-result (TTR), sensitivity, and reproducibility. The results showed a record 4x improvement in TTR, enabling the biosensor to return test results in under one minute. The Company\u2019s biosensor platform is the world\u2019s first platform designed to specifically support multiple non-invasive, real-time, saliva-based diagnostic tests based on &hellip; Continue reading &quot;Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-23T12:33:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development\",\"datePublished\":\"2023-01-23T12:33:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/\"},\"wordCount\":884,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/\",\"name\":\"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\",\"datePublished\":\"2023-01-23T12:33:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/","og_locale":"en_US","og_type":"article","og_title":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk","og_description":"Achieves Record 4x Improvement in Time-To-Result to Provide\u00a0Test Results in Under 1 Minute NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Intelligent Bio Solutions Inc. (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a phase of its biosensor platform development at the University of Newcastle, Australia, that included testing time-to-result (TTR), sensitivity, and reproducibility. The results showed a record 4x improvement in TTR, enabling the biosensor to return test results in under one minute. The Company\u2019s biosensor platform is the world\u2019s first platform designed to specifically support multiple non-invasive, real-time, saliva-based diagnostic tests based on &hellip; Continue reading \"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-23T12:33:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development","datePublished":"2023-01-23T12:33:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/"},"wordCount":884,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/","name":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=","datePublished":"2023-01-23T12:33:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDA4MSM1MzY2MzkzIzIxODk1NjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-reaches-key-milestone-in-biosensor-platform-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=724911"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724911\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=724911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=724911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=724911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}